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The family of cholinesterases, including acetylcholinesterase
(AChE) and butyrylcholinesterase (BChE), has been of significant
interest to neuroscientists for several decades. Cholinesterases
play an essential role in mediating neurotransmission in cholin-
ergic synapses, which control the higher brain functions such
as learning and memory; they also are causally involved in con-
trolling nerve-muscle communication and muscle activities, and
serve as an important component of the physiological differ-
ences characteristic of certain pathological conditions. A notable
example is Alzheimer’s disease, where premature death of cholin-
ergic neurons has been the basis for drug development so that
the leading therapeutic agents available to date are targeted to
inhibit cholinesterase activities. AChE and BChE were initially
identified as efficient hydrolases that possess the capacity to
rapidly hydrolyze acetylcholine and butyrylcholine, respectively;
and AChE presents more rapid and far more selective potency for
such hydrolysis compared to BChE. Throughout the last 40 years,
multiple studies of cholinesterases led to an exponential increase
in the effort to explore their functions, structures and physiolog-
ical roles in health and disease. The resultant findings strongly
suggest vital roles for cholinesterases both in the nervous system
and in other body systems, with non-neuronal functions such
as the regulation of apoptosis and inflammation being a rela-
tively new focus of interest. This vast interest, coupled with the
rapid increase in the availability and power of different research
tools allow far deeper understanding of the structure and func-
tions of AChE and BChE in different disciplinary terms, including
cellular and molecular biology, genetics and epigenetics, phys-
iology, structure-function relationships at an atomic resolution
level, the chemical mechanisms of enzymatic inhibition, phar-
macology, drug development, disease therapy, etc. However, in
spite of this massive multi-disciplinary effort, numerous crit-
ical and core questions of AChE and BChE are yet not fully
answered, and some have never been addressed as yet. As two
of the many enthusiastic scientists in this field, we believe that
the current surge in cholinesterase research will further expand
in the near future. Therefore, it has been an honor to co-edit
this E-book, entitled “Acetylcholinesterase: old questions and new
developments.” This volume includes pertinent research articles
by 11 leading groups, worldwide (Carvajal and Inestrosa, 2011;
Chen et al., 2011; García-Ayllón et al., 2011; Hanin and Soreq,
2011; Bronicki and Jasmin, 2012; Durrant et al., 2012; Falugi
and Aluigi, 2012; Gilboa-Geffen et al., 2012; Gnatek et al., 2012;
Shehadeh Masha’our et al., 2012; Zhang and Greenberg, 2012).
It covers the translational and post-translational modifications of
cholinesterases, their developmental expression patterns in dif-
ferent species, their links to inflammation-related pathologies
and their role in apoptotic processes. At the molecular level,
one can find in this volume a reference to the microRNA reg-
ulation of cholinesterases as well as to the trans-acting factors
governing the metabolism of cholinesterase mRNA. Also, the
links of cholinesterases with inherited neuromuscular diseases as
well as with Alzheimer’s neuropathology and therapeutics is cov-
ered from both the physiological and structural points of view.
Thus, this volume provides a glimpse into the most up-to-date
research information in the diverse field of cholinesterases, as well
as an important insight for outlying future research directions
in this topic.
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